诱导毒性的分子机制及其修改
Jin-Yong Lee1, Maki Tokumoto1, Masahiko Satoh1
1Laboratory of Public Health, School of Pharmacy, Aichi Gakuin University, Kusumoto-cho 1-100, Chikusa-ku, Nagoya 464-8650, Japan.
International journal of molecular sciences
|August 14, 2025
概括
(Cd) 毒性机制涉及YY1和FOXF1等转录因子,影响细胞死亡和铁的吸收. 这解释了CD诱导的贫血和损伤.
科学领域:
- 环境毒理学环境毒理学
- 分子生物学分子生物学
- 重金属的毒性重金属的毒性
背景情况:
- (Cd) 是一种有毒的环境重金属,会影响多个器官.
- 对于Cd毒性的分子机制尚未完全理解.
- 暴露于CD与贫血和器官损伤有关.
研究的目的:
- 审查Cd毒性的近期分子机制.
- 突出新型分子点和受Cd.影响的途径.
- 为Cd诱导的贫血提供一种机制基础.
主要方法:
- 通过DNA微阵列分析分析.
- 蛋白质-DNA结合测定试验
- 通过siRNA介导的基因沉默.
- 对亡,ROS,ferroptosis和pyroptosis途径的审查
主要成果:
- 确定了YY1,FOXF1,ARNT和MEF2A作为新的Cd分子标.
- 与细胞毒性相关的UBE2D2,UBE2D4,BIRC3和SLC2A4的下调.
- PPARδ通过亡途径调节Cd诱导的毒性.
- Cd抑制铁运输基因,损害肠道吸收,并减少肝脏的铁.
结论:
- 细胞毒性涉及关键转录因子和下游基因的破坏.
- Cd诱导的毒性是由PPARδ和亡调节的.
- 破坏铁的稳态有助于Cd诱导的缺铁性贫血.
相关概念视频
Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Coronary Artery Disease I: Introduction
55
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
Structure of Cadherins
3.6K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins” is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
3.6K
Coronary Artery Disease II: Pathophysiology
35
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
35
The Periodic Table and Organismal Elements
185.7K
Overview
185.7K


